Patent intelligence · US
US 9132096
Abuse resistant pharmaceutical compositions
Abuse resistant pharmaceutical compositions
Patent details — US 9132096
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 15, 2015
- Expiration
- Sep 10, 2035
- Applicant
- REKHI GURVINDER SINGH [US]
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 50 A I, A61K 31/ 485 A I, A61K 47/ 02 A I
Quick answer
US 9132096 (Abuse resistant pharmaceutical compositions) is held by REKHI GURVINDER SINGH [US]. Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- REKHI GURVINDER SINGH [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 50 A I, A61K 31/ 485 A I, A61K 47/ 02 A I, A61K 47/ 10 A I, A61K 47/ 14 A I
Frequently asked questions
What is US patent 9132096?
US 9132096 (Abuse resistant pharmaceutical compositions) is held by REKHI GURVINDER SINGH [US]. Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9132096?
REKHI GURVINDER SINGH [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 9132096 expire?
Our index shows an expiration date of Sep 10, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.